Altitude Crest Partners Inc. Bridge Bio Pharma, Inc. Transaction History
Altitude Crest Partners Inc.
- $234 Billion
- Q1 2024
A detailed history of Altitude Crest Partners Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Altitude Crest Partners Inc. holds 612,060 shares of BBIO stock, worth $15.5 Million. This represents 8.1% of its overall portfolio holdings.
Number of Shares
612,060
Previous 754,560
18.89%
Holding current value
$15.5 Million
Previous $30.5 Billion
37.87%
% of portfolio
8.1%
Previous 20.38%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
284Shares Held
170MCall Options Held
7.41MPut Options Held
2.61M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$787 Million40.56% of portfolio
-
Viking Global Investors LP25.1MShares$636 Million2.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.2MShares$335 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$265 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$154 Million64.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.76B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...